Information on the Target
Best Health, a prominent Moroccan firm specializing in the distribution and installation of medical equipment for hospitals and clinics in Morocco and Tunisia, recently acquired Mabiotech. Mabiotech ranks as the third largest distributor of in-vitro diagnostic devices and reagents for public and private medical laboratories. This acquisition marks a significant milestone for Best Health, which operates under Amethis Maghreb Fund I.
Mabiotech offers a comprehensive portfolio of products that cover key specialties in the industry, including immunology, biochemistry, hematology, and microbiology. With longstanding exclusive relationships with top-tier suppliers like Beckman Coulters and a strong reputation for customer service, Mabiotech has solidified its position as a market leader, particularly amplified by the demand for testing solutions during the COVID-19 pandemic.
Industry Overview in Morocco
The healthcare sector in Morocco has been experiencing substantial growth, supported by the government's Health Plan 2025, which aims to expand universal health coverage, enhance healthcare spending, and improve hospital infrastructure. This includes the establishment of new medical biology laboratories in public hospitals, which are essential to cater to the growing healthcare needs of the population.
In-vitro diagnostics is a crucial segment within the broader healthcare industry, playing a vital role in disease prevention, diagnostics, and monitoring. This field is expected to witness robust growth, as advances in technology and rising healthcare awareness lead to increased demand for diagnostic tests across various healthcare settings, further fueling market expansion.
Moreover, the COVID-19 pandemic has underscored the importance of diagnostic capabilities, generating a surge in demand for testing solutions, which has positively influenced the operational landscape for companies within this sector. This trend is anticipated to continue as the healthcare industry evolves to address emerging challenges and patient needs.
The Rationale Behind the DealThe acquisition of Mabiotech represents a strategic opportunity for Best Health to enhance its market presence and expand its customer base across Mor…